Epoetin alfa
Showing 26 - 50 of 1,722
Anemia, Dialysis-Dependent Chronic Kidney Disease Trial in United States (vadadustat, epoetin alfa)
Terminated
- Anemia
- Dialysis-Dependent Chronic Kidney Disease
- vadadustat
- epoetin alfa
-
Bakersfield, California
- +17 more
Feb 2, 2021
Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in United States (biological, other, drug)
Active, not recruiting
- Anemia
- +3 more
- Epoetin Alfa
- +2 more
-
Birmingham, Alabama
- +512 more
Mar 1, 2022
Anemia, Chronic Kidney Disease Trial (Epoetin Alfa, Darbepoetin alfa)
Completed
- Anemia
- Chronic Kidney Disease
- Epoetin Alfa
- Darbepoetin alfa
- (no location specified)
Aug 16, 2019
CKD Anemia in Stable Dialysis Patients Trial in Puerto Rico, United States (Epoetin Alfa, Roxadustat)
Completed
- CKD Anemia in Stable Dialysis Patients
- Epoetin Alfa
- Roxadustat
-
Phoenix, Arizona
- +75 more
Sep 30, 2021
Hypoxic-Ischemic Encephalopathy Trial in Australia, New Zealand, Singapore (Epoetin Alfa, Normal saline)
Active, not recruiting
- Hypoxic-Ischemic Encephalopathy
- Epoetin Alfa
- Normal saline
-
Garran, Australian Capital Territory, Australia
- +23 more
Apr 26, 2021
Anemia Trial in France (Methoxy Polyethylene Glycol-epoetin Beta)
Completed
- Anemia
- Methoxy Polyethylene Glycol-epoetin Beta
-
Aix En Provence, France
- +68 more
Sep 9, 2021
Intraventricular Hemorrhage of Prematurity Trial (MLT+EPO, Placebo)
Not yet recruiting
- Intraventricular Hemorrhage of Prematurity
- MLT+EPO
- Placebo
- (no location specified)
Jan 5, 2023
End Stage Renal Disease Trial in Cairo (dietary supplement, other, drug)
Completed
- End Stage Renal Disease
- Zinc Sulphate
- +3 more
-
Cairo, El Matareya, EgyptNational Institute of Urology and Nephrology
Jan 18, 2020
Anemia, Renal Insufficiency, Chronic Trial in Japan, United States (Molidustat (BAY85-3934), Epoetin alfa/beta)
Completed
- Anemia
- Renal Insufficiency, Chronic
- Molidustat (BAY85-3934)
- Epoetin alfa/beta
-
Azusa, California
- +25 more
Sep 17, 2019
Hepatitis C, HIV Trial in Badalona, Barcelona (Peginterferón alfa-2a (40 KD) (Pegasys®) 180 ug/week, Ribavirin (Copegus®) 1600
Completed
- Hepatitis C
- HIV Infections
- Peginterferón alfa-2a (40 KD) (Pegasys®) 180 ug/week
- +2 more
-
Badalona, Barcelona, Spain
- +1 more
Dec 3, 2019
Acute Kidney Injury, Cardiac Disease, Surgery Trial in Nanjing (Erythropoietin, 0.9% sodium chloride, cardiac surgery)
Terminated
- Acute Kidney Injury
- +2 more
- Erythropoietin
- +2 more
-
Nanjing, Jiangsu, ChinaNanjing First Hospital
Jan 8, 2023
Anemia, Renal Insufficiency, Chronic Trial in Japan, United States (Molidustat (BAY 85-3934), Epoetin alfa/beta)
Completed
- Anemia
- Renal Insufficiency, Chronic
- Molidustat (BAY 85-3934)
- Epoetin alfa/beta
-
Azusa, California
- +34 more
Sep 17, 2019
Natural Blood and Blood Product Toxicity Trial in Dhaka (Erythropoietin alpha)
Completed
- Natural Blood and Blood Product Toxicity
- Erythropoietin alpha
-
Dhaka, Bangladesh
- +1 more
Oct 18, 2022
Conjunctival and Scleral Avascular Lesions Trial in Tehran (Prescription of , Erythropoietin prescription)
Enrolling by invitation
- Conjunctival and Scleral Avascular Lesions
- Prescription of placebo
- Erythropoietin prescription
-
Tehran, Iran, Islamic Republic ofOphthalmic Research center
Jul 25, 2022
Total Knee Arthroplasty Trial in Chengdu (Ferric Derisomaltose Injection (Monoferric) and Human Erythropoietin Injection
Not yet recruiting
- Total Knee Arthroplasty
- Ferric Derisomaltose Injection (Monoferric) and Human Erythropoietin Injection (EPIAO)
- Basic Treatment
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Jun 20, 2023
Liver Transplant Rejection Trial in Chicago (Erythropoietin)
Recruiting
- Liver Transplant Rejection
-
Chicago, IllinoisNorthwestern University
Apr 5, 2022
Anemia in Incident Dialysis Patients Trial in Worldwide (Roxadustat, Epoetin Alfa)
Completed
- Anemia in Incident Dialysis Patients
- Roxadustat
- Epoetin Alfa
-
Chula Vista, California
- +112 more
Sep 1, 2021
Acute Respiratory Distress Syndrome Trial in Wenzhou (Human erythropoietin injection, 0.9%NaCl)
Recruiting
- Acute Respiratory Distress Syndrome
- Human erythropoietin injection
- 0.9%NaCl
-
Wenzhou, Zhejiang, ChinaSAHWenzhouMU
May 4, 2023
Healthy Trial (Experimental Erythropoietin subcutaneous injection single dose of 4,000 IU, Active comparator Erythropoietin
Not yet recruiting
- Healthy
- Experimental Erythropoietin subcutaneous injection single dose of 4,000 IU
- Active comparator Erythropoietin Eprex® subcutaneous injection single dose of 4,000 IU
- (no location specified)
Apr 8, 2022